Anti-TNF, thiopurine combination increase lymphoma risk in IBD

Patients with inflammatory bowel disease treated with anti-TNF either as a monotherapy or in combination with thiopurines are at increased risk for lymphoma, according to study results.

Read the full article here

Related Articles